Taxonomy of Burkholderia Cepacia Complex Species (and Frequency in Cystic Fibrosis Patients in the United States) (see Cystic Fibrosis, [[Cystic Fibrosis]]) (Curr Opin Pulm Med, 2005) [MEDLINE]
Burkholderia Cepacia (Genomovar I): 3% of cystic fibrosis patients
Burkholderia Multivorans (Genomovar II): 40% of cystic fibrosis patients
Burkholderia Cenocepacia (Genomovar III): 45% of cystic fibrosis patients
Burkholderia Stabilis (Genomovar IV): <1% of cystic fibrosis patients
Burkholderia Vietnamiensis (Genomovar V): 6% of cystic fibrosis patients
Burkholderia Dolosa (Genomovar VI): 4% of cystic fibrosis patients
Burkholderia Ambifaria (Genomovar VII): 1% of cystic fibrosis patients
Burkholderia Anthina (Genomovar VIII): <1% of cystic fibrosis patients
Burkholderia Pyrrocinia (Genomovar IX): <1% of cystic fibrosis patients
Centers for Disease Control and Prevention. Healthcare-assocated infection. Multistate outbreak of Burkholderia cepacia infections. httpss://www.cdc.gov/hai/outbreaks/b-cepacia/index.html
US Food and Drug Administration. Oral liquid docusate sodium by PharmaTech: Recall – contaminated with B. cepacia. https://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm511528.htm
Outcome of Burkholderia cepacia colonisation in an adult cystic fibrosis centre. Thorax 2002; 57:142—145 [MEDLINE]
Prevalence and clonality of Burkholderia cepacia complex genomovars in UK patients with cystic fibrosis referred for lung transplantation. Thorax 2004; 59:526—528 [MEDLINE]
Clinical outcome of Burkholderia cepacia complex infection in cystic fibrosis adults. J Cyst Fibros 2004; 3: 93—98 [MEDLINE]
Burkholderia cenocepacia and Burkholderia multivorans: influence on survival in cystic fibrosis. Thorax 2004; 59:948—951 [MEDLINE]
Update on the Burkholderia cepacia complex. Curr Opin Pulm Med. 2005 Nov;11(6):528-33 [MEDLINE]